US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TuHURA Biosciences, Inc.

2.05

0.0000

Volume:167.35K

Turnover:349.56K

Market Cap:130.34M

PE:-3.78

High:2.16

Open:2.05

Low:2.05

Close:2.05

52wk High:3.43

52wk Low:0.4100

Shares:63.58M

Float Shares:39.66M

Volume Ratio:0.68

T/O Rate:0.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5428

EPS(LYR):-0.6272

ROE:-161.39%

ROA:-58.43%

PB:7.15

PE(LYR):-3.27

Loading ...

Overview Company News Filings

TuHURA Biosciences: FDA clears IND for TBS-2025 VISTA-inhibiting antibody

TuHURA Biosciences Wins FDA IND Clearance for TBS-2025 in mutNPM1 AML Study

Tuhura Biosciences - Study Expected to Progress to Dose-Optimization Stage After FDA Safety Review

THOMSON REUTERS

Tuhura Biosciences Receives FDA "Study May Proceed" Notice and Ind Clearance for the Evaluation of Its Tbs-2025 Vista-Inhibiting Antibody in Molecularly Defined Subsets of Aml and Other Blood-Related Cancers

THOMSON REUTERS

Tuhura Biosciences - May Explore Trial Expansion & Accelerated Approval with FDA if Response Rates Encouraging

THOMSON REUTERS

TuHURA Biosciences CEO Bianco to Present at H.C. Wainwright Global Investment Conference

Tuhura Biosciences Draws $1.5 Million from Parkview Holdings Revolving Credit Facility

Analysts’ Top Healthcare Picks: CVS Health (CVS), TuHURA Biosciences (HURA)

Tuhura Biosciences Draws $650,000 from Parkview Revolving Credit Facility

Tuhura Biosciences Holds Annual Shareholder Meeting

TuHURA Biosciences Price Target Maintained with a $9.00/Share by Citizens

TuHURA Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

TuHURA Biosciences Q2 EPS $(0.14) Beats $(0.15) Estimate

Benzinga Earnings

Tuhura Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

THOMSON REUTERS

Press Release: TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Tuhura Biosciences Draws $650,000 from Parkview Revolving Credit Facility

TuHURA Biosciences Inc Expected to Post a Loss of 14 Cents a Share - Earnings Preview

Tuhura Biosciences Releases Corporate Deck Outlining Strategy to Tackle Cancer Immunotherapy Resistance

Tuhura Biosciences Draws $1.5 Million from Parkview Revolving Credit Facility

Tuhura Biosciences Draws $1.9 Million from Parkview Revolving Credit Facility

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/HURA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HURA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HURA\",,,,,undefined,":{"symbol":"HURA","market":"US","secType":"STK","nameCN":"TuHURA Biosciences, Inc.","latestPrice":2.05,"timestamp":1789416000000,"preClose":2.05,"halted":0,"volume":167345,"delay":0,"changeRate":0,"floatShares":39657200,"shares":63578528,"eps":-0.542788,"marketStatus":"Pre-Mkt","change":0,"latestTime":"09-15 06:51:14 EDT","open":2.05,"high":2.16,"low":2.05,"amount":349563.6738035,"amplitude":0.053659,"askPrice":2.31,"askSize":100,"bidPrice":0.8222,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.542788,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":2.05,"postHourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.05,"latestTime":"19:38 EDT","volume":199,"amount":408.2475,"timestamp":1789429119406,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6792508741376896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HURA\",,,,,undefined,":{"symbol":"HURA","floatShares":39657200,"roa":"-58.43%","roe":"-161.39%","lyrEps":-0.627208,"volumeRatio":0.6792508741376896,"shares":63578528,"dividePrice":0,"high":2.16,"amplitude":0.053659,"preClose":2.05,"low":2.05,"week52Low":0.41,"pbRate":"7.15","week52High":3.43,"institutionHeld":0,"latestPrice":2.05,"eps":-0.542788,"divideRate":0,"volume":167345,"delay":0,"ttmEps":-0.542788,"open":2.05,"prevYearClose":0.7567,"prevWeekClose":2.05,"prevMonthClose":2.13,"prevQuarterClose":2.34,"fiveDayClose":2.14,"twentyDayClose":2.47,"sixtyDayClose":2.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HURA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"HURA","fiscalQuarterEnding":"2026/06","expectedEps":-0.15,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2026-05-15","symbol":"HURA","fiscalQuarterEnding":"2026/03","expectedEps":-0.11,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2026-03-31","symbol":"HURA","fiscalQuarterEnding":"2025/12","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-11-14","symbol":"HURA","fiscalQuarterEnding":"2025/09","expectedEps":-0.15,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-08-14","symbol":"HURA","fiscalQuarterEnding":"2025/06","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.21}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HURA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HURA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1777521600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HURA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HURA","date":"2026-09-14","current":-3.776797,"percent":0.747323,"low":-15.284879,"twenty":-7.639228,"median":-4.763162,"eighty":-4.044413,"high":-0.912265,"avg":-5.490892,"sd":2.638334,"marketCap":130639564},"quantilePoints":[{"date":"2024-10-31","current":-8.730961,"twenty":-7.999797,"median":-7.383325,"eighty":-6.996296,"marketCap":255964076},{"date":"2024-11-08","current":-7.555364,"twenty":-8.206244,"median":-7.555364,"eighty":-7.208419,"marketCap":221499291},{"date":"2024-11-15","current":-7.024911,"twenty":-7.675791,"median":-7.239959,"eighty":-7.070789,"marketCap":205948107},{"date":"2024-11-22","current":-7.665321,"twenty":-7.599347,"median":-7.225623,"eighty":-6.910219,"marketCap":140801257},{"date":"2024-11-29","current":-15.010301,"twenty":-7.933971,"median":-7.512354,"eighty":-7.036381,"marketCap":275718282},{"date":"2024-12-06","current":-13.866223,"twenty":-11.098214,"median":-7.555364,"eighty":-7.065054,"marketCap":254703169},{"date":"2024-12-13","current":-12.310277,"twenty":-13.486389,"median":-7.688203,"eighty":-7.082258,"marketCap":226122615},{"date":"2024-12-20","current":-9.152622,"twenty":-13.106555,"median":-8.294564,"eighty":-7.105196,"marketCap":168120904},{"date":"2024-12-27","current":-10.411108,"twenty":-12.712992,"median":-8.730961,"eighty":-7.156808,"marketCap":191237528},{"date":"2025-01-03","current":-9.404319,"twenty":-12.676382,"median":-9.175503,"eighty":-7.225623,"marketCap":172744228},{"date":"2025-01-10","current":-9.541609,"twenty":-12.383498,"median":-9.381438,"eighty":-7.248561,"marketCap":175266042},{"date":"2025-01-17","current":-10.822976,"twenty":-11.486541,"median":-9.518727,"eighty":-7.460742,"marketCap":198802968},{"date":"2025-01-24","current":-10.571279,"twenty":-11.170776,"median":-9.724661,"eighty":-7.521761,"marketCap":194179644},{"date":"2025-01-31","current":-11.325839,"twenty":-11.2987,"median":-9.861951,"eighty":-7.544431,"marketCap":208039858},{"date":"2025-02-07","current":-10.266919,"twenty":-11.2987,"median":-10.022121,"eighty":-7.555364,"marketCap":188588977},{"date":"2025-02-14","current":-10.552406,"twenty":-11.252498,"median":-10.136529,"eighty":-7.621338,"marketCap":193832969},{"date":"2025-02-21","current":-7.603262,"twenty":-11.206135,"median":-9.999239,"eighty":-7.574523,"marketCap":139661309},{"date":"2025-02-28","current":-5.806127,"twenty":-11.137841,"median":-9.861951,"eighty":-7.518625,"marketCap":106650454},{"date":"2025-03-07","current":-4.700198,"twenty":-11.042639,"median":-9.689249,"eighty":-7.174012,"marketCap":86336082},{"date":"2025-03-14","current":-4.561957,"twenty":-10.951113,"median":-9.541609,"eighty":-7.036381,"marketCap":83796785},{"date":"2025-03-21","current":-9.216075,"twenty":-10.928231,"median":-9.438641,"eighty":-6.704264,"marketCap":169286436},{"date":"2025-03-28","current":-8.340548,"twenty":-10.90535,"median":-9.216075,"eighty":-6.852872,"marketCap":153204224},{"date":"2025-04-04","current":-6.636447,"twenty":-10.864163,"median":-9.011547,"eighty":-6.704264,"marketCap":143893470},{"date":"2025-04-11","current":-7.796363,"twenty":-10.722297,"median":-8.730961,"eighty":-6.759947,"marketCap":169043136},{"date":"2025-04-17","current":-8.340296,"twenty":-10.567504,"median":-8.501461,"eighty":-6.795924,"marketCap":180836843},{"date":"2025-04-25","current":-8.521606,"twenty":-10.542452,"median":-8.46117,"eighty":-6.852364,"marketCap":184768079},{"date":"2025-05-02","current":-7.8568,"twenty":-10.498764,"median":-8.409668,"eighty":-7.030646,"marketCap":170353548},{"date":"2025-05-09","current":-7.917237,"twenty":-10.46885,"median":-8.350494,"eighty":-7.05932,"marketCap":171663960},{"date":"2025-05-16","current":-7.735926,"twenty":-10.401955,"median":-8.271427,"eighty":-7.082258,"marketCap":167732724},{"date":"2025-05-23","current":-5.593729,"twenty":-10.356677,"median":-8.259713,"eighty":-7.009861,"marketCap":131477994},{"date":"2025-05-30","current":-5.909654,"twenty":-10.322004,"median":-8.210864,"eighty":-6.792598,"marketCap":138903659},{"date":"2025-06-06","current":-5.370723,"twenty":-10.312959,"median":-8.038111,"eighty":-6.609295,"marketCap":126236344},{"date":"2025-06-13","current":-4.86896,"twenty":-10.273819,"median":-7.961523,"eighty":-5.965405,"marketCap":114442640},{"date":"2025-06-20","current":-5.01763,"twenty":-10.268299,"median":-7.907165,"eighty":-5.77585,"marketCap":117937071},{"date":"2025-06-27","current":-4.255694,"twenty":-10.254133,"median":-7.8568,"eighty":-5.590128,"marketCap":100028109},{"date":"2025-07-03","current":-4.911411,"twenty":-10.238281,"median":-7.856432,"eighty":-5.456208,"marketCap":115440443},{"date":"2025-07-11","current":-4.990628,"twenty":-10.201312,"median":-7.766145,"eighty":-5.256797,"marketCap":117302386},{"date":"2025-07-18","current":-5.010432,"twenty":-10.182292,"median":-7.688203,"eighty":-5.039996,"marketCap":117767871},{"date":"2025-07-25","current":-5.624358,"twenty":-10.127376,"median":-7.668851,"eighty":-5.052895,"marketCap":132197927},{"date":"2025-08-01","current":-4.911411,"twenty":-10.049579,"median":-7.615053,"eighty":-5.052895,"marketCap":115440443},{"date":"2025-08-08","current":-4.812391,"twenty":-9.994663,"median":-7.555364,"eighty":-5.037142,"marketCap":113113015},{"date":"2025-08-15","current":-4.975285,"twenty":-9.907714,"median":-7.528032,"eighty":-5.017728,"marketCap":138129515},{"date":"2025-08-22","current":-5.245681,"twenty":-9.861951,"median":-7.477167,"eighty":-5.037142,"marketCap":145636554},{"date":"2025-08-29","current":-5.065417,"twenty":-9.847676,"median":-7.326779,"eighty":-5.052895,"marketCap":140631862},{"date":"2025-09-05","current":-4.560678,"twenty":-9.79276,"median":-7.254296,"eighty":-5.013311,"marketCap":126618722},{"date":"2025-09-12","current":-4.668836,"twenty":-9.696332,"median":-7.110931,"eighty":-4.956091,"marketCap":129621538},{"date":"2025-09-19","current":-4.65081,"twenty":-9.618099,"median":-7.053585,"eighty":-4.911411,"marketCap":129121069},{"date":"2025-09-26","current":-4.416467,"twenty":-9.555338,"median":-6.959639,"eighty":-4.875184,"marketCap":122614968},{"date":"2025-10-03","current":-4.704889,"twenty":-9.532456,"median":-6.792598,"eighty":-4.824615,"marketCap":130622476},{"date":"2025-10-10","current":-4.65081,"twenty":-9.500422,"median":-6.659051,"eighty":-4.759515,"marketCap":129121069},{"date":"2025-10-17","current":-4.326335,"twenty":-9.445506,"median":-6.451252,"eighty":-4.704889,"marketCap":120112622},{"date":"2025-10-24","current":-4.019886,"twenty":-9.386014,"median":-6.151486,"eighty":-4.692197,"marketCap":111604644},{"date":"2025-10-31","current":-4.470546,"twenty":-9.301564,"median":-5.965405,"eighty":-4.668836,"marketCap":124116376},{"date":"2025-11-07","current":-4.416467,"twenty":-9.208999,"median":-5.850391,"eighty":-4.621968,"marketCap":122614968},{"date":"2025-11-14","current":-3.677385,"twenty":-9.18008,"median":-5.798151,"eighty":-4.596731,"marketCap":102095729},{"date":"2025-11-21","current":-2.774116,"twenty":-9.039762,"median":-5.662432,"eighty":-4.565822,"marketCap":81244064},{"date":"2025-11-28","current":-3.500461,"twenty":-8.84257,"median":-5.63426,"eighty":-4.556086,"marketCap":102516170},{"date":"2025-12-05","current":-3.465457,"twenty":-8.730961,"median":-5.593729,"eighty":-4.544729,"marketCap":101491008},{"date":"2025-12-12","current":-1.811489,"twenty":-8.705462,"median":-5.561421,"eighty":-4.506599,"marketCap":53052117},{"date":"2025-12-19","current":-1.552105,"twenty":-8.587093,"median":-5.505534,"eighty":-4.470546,"marketCap":45455669},{"date":"2025-12-26","current":-1.707387,"twenty":-8.521606,"median":-5.445058,"eighty":-4.45252,"marketCap":50003338},{"date":"2026-01-02","current":-1.568888,"twenty":-8.50549,"median":-5.407919,"eighty":-4.416467,"marketCap":45947208},{"date":"2026-01-09","current":-1.564327,"twenty":-8.469228,"median":-5.371294,"eighty":-4.409256,"marketCap":45813623},{"date":"2026-01-16","current":-1.57656,"twenty":-8.46117,"median":-5.317787,"eighty":-4.331172,"marketCap":46171874},{"date":"2026-01-23","current":-1.408413,"twenty":-8.46117,"median":-5.267885,"eighty":-4.319125,"marketCap":41247441},{"date":"2026-01-30","current":-1.163138,"twenty":-8.430269,"median":-5.249422,"eighty":-4.265631,"marketCap":34064204},{"date":"2026-02-06","current":-0.912265,"twenty":-8.395844,"median":-5.227655,"eighty":-4.145319,"marketCap":26717023},{"date":"2026-02-13","current":-2.881928,"twenty":-8.370916,"median":-5.188669,"eighty":-4.09774,"marketCap":84401506},{"date":"2026-02-20","current":-2.301396,"twenty":-8.352484,"median":-5.119354,"eighty":-3.87886,"marketCap":67399763},{"date":"2026-02-27","current":-3.358794,"twenty":-8.340447,"median":-5.054798,"eighty":-3.490101,"marketCap":98367222},{"date":"2026-03-06","current":-3.234394,"twenty":-8.312748,"median":-5.017712,"eighty":-3.42514,"marketCap":94723992},{"date":"2026-03-13","current":-4.063726,"twenty":-8.270771,"median":-4.990628,"eighty":-3.42514,"marketCap":119012195},{"date":"2026-03-20","current":-3.71126,"twenty":-8.265757,"median":-4.95929,"eighty":-3.463659,"marketCap":108689709},{"date":"2026-03-27","current":-4.042992,"twenty":-8.259713,"median":-4.911411,"eighty":-3.465457,"marketCap":118404990},{"date":"2026-04-02","current":-3.427302,"twenty":-8.251655,"median":-4.911411,"eighty":-3.465457,"marketCap":102997215},{"date":"2026-04-10","current":-4.146613,"twenty":-8.215999,"median":-4.888063,"eighty":-3.434334,"marketCap":124613914},{"date":"2026-04-17","current":-6.262232,"twenty":-8.188482,"median":-4.911411,"eighty":-3.463059,"marketCap":188192442},{"date":"2026-04-24","current":-4.844767,"twenty":-8.114171,"median":-4.911411,"eighty":-3.465457,"marketCap":145594829},{"date":"2026-05-01","current":-4.738986,"twenty":-8.030053,"median":-4.911411,"eighty":-3.469004,"marketCap":142415902},{"date":"2026-05-08","current":-5.077485,"twenty":-7.995389,"median":-4.911411,"eighty":-3.486647,"marketCap":152588467},{"date":"2026-05-15","current":-5.310203,"twenty":-7.976007,"median":-4.911411,"eighty":-3.500461,"marketCap":159582105},{"date":"2026-05-22","current":-4.818786,"twenty":-7.933354,"median":-4.916581,"eighty":-3.501154,"marketCap":149017115},{"date":"2026-05-29","current":-4.839379,"twenty":-7.917237,"median":-4.916581,"eighty":-3.503927,"marketCap":149653940},{"date":"2026-06-05","current":-4.509889,"twenty":-7.897092,"median":-4.911411,"eighty":-3.58686,"marketCap":139464736},{"date":"2026-06-12","current":-4.509889,"twenty":-7.897092,"median":-4.904697,"eighty":-3.677385,"marketCap":139464736},{"date":"2026-06-18","current":-4.571669,"twenty":-7.864858,"median":-4.888063,"eighty":-3.704485,"marketCap":141375212},{"date":"2026-06-26","current":-5.333613,"twenty":-7.8568,"median":-4.908236,"eighty":-3.727846,"marketCap":164937747},{"date":"2026-07-02","current":-5.04531,"twenty":-7.856579,"median":-4.901158,"eighty":-3.744433,"marketCap":156022193},{"date":"2026-07-10","current":-4.818786,"twenty":-7.844566,"median":-4.888063,"eighty":-3.771996,"marketCap":149017115},{"date":"2026-07-17","current":-4.571669,"twenty":-7.81248,"median":-4.891607,"eighty":-3.786112,"marketCap":141375212},{"date":"2026-07-24","current":-4.427517,"twenty":-7.760101,"median":-4.868044,"eighty":-3.812345,"marketCap":136917435},{"date":"2026-07-31","current":-4.468703,"twenty":-7.71981,"median":-4.860726,"eighty":-3.856706,"marketCap":138191085},{"date":"2026-08-07","current":-4.355441,"twenty":-7.692662,"median":-4.839379,"eighty":-3.914446,"marketCap":134688546},{"date":"2026-08-14","current":-4.736413,"twenty":-7.681875,"median":-4.818786,"eighty":-3.97155,"marketCap":146469814},{"date":"2026-08-21","current":-4.616534,"twenty":-7.672382,"median":-4.818786,"eighty":-4.019886,"marketCap":141375212},{"date":"2026-08-28","current":-4.432444,"twenty":-7.669558,"median":-4.813895,"eighty":-4.020835,"marketCap":135737694},{"date":"2026-09-04","current":-4.370015,"twenty":-7.66133,"median":-4.7776,"eighty":-4.030552,"marketCap":133825895},{"date":"2026-09-11","current":-4.224348,"twenty":-7.647286,"median":-4.769319,"eighty":-4.043702,"marketCap":129365032},{"date":"2026-09-14","current":-4.265967,"twenty":-7.639228,"median":-4.763162,"eighty":-4.044413,"marketCap":130639564}],"updateTime":1789469474198},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HURA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667665822","title":"TuHURA Biosciences: FDA clears IND for TBS-2025 VISTA-inhibiting antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2667665822","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667665822?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:50","pubTimestamp":1789386637,"startTime":"0","endTime":"0","summary":"TuHURA Biosciences (HURA) announced that the U.S. FDA has given clearance to TuHURA’s Investigational New Drug application for its TBS-2025 VISTA-i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tuhura-biosciences-fda-clears-ind-for-tbs-2025-vista-inhibiting-antibody-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tuhura-biosciences-fda-clears-ind-for-tbs-2025-vista-inhibiting-antibody-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HURA","BK4588","BK4139","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663112","title":"TuHURA Biosciences Wins FDA IND Clearance for TBS-2025 in mutNPM1 AML Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663112","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663112?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:45","pubTimestamp":1789386321,"startTime":"0","endTime":"0","summary":"TuHURA Biosciences wins FDA IND clearance for TBS-2025 in mutNPM1 AML studyTuHURA Biosciences received FDA IND clearance for TBS-2025, a VISTA-inhibiting antibody, in molecularly defined subsets of AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL4zrJHM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663197","title":"Tuhura Biosciences - Study Expected to Progress to Dose-Optimization Stage After FDA Safety Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663197?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:45","pubTimestamp":1789386300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA69VJWN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663113","title":"Tuhura Biosciences Receives FDA \"Study May Proceed\" Notice and Ind Clearance for the Evaluation of Its Tbs-2025 Vista-Inhibiting Antibody in Molecularly Defined Subsets of Aml and Other Blood-Related Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663113","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663113?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:45","pubTimestamp":1789386300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA69VJWN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667115663","title":"Tuhura Biosciences - May Explore Trial Expansion & Accelerated Approval with FDA if Response Rates Encouraging","url":"https://stock-news.laohu8.com/highlight/detail?id=2667115663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667115663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:45","pubTimestamp":1789386300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA69VJWN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665632724","title":"TuHURA Biosciences CEO Bianco to Present at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665632724","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665632724?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:45","pubTimestamp":1788867925,"startTime":"0","endTime":"0","summary":"TuHURA Biosciences CEO Bianco to present at H.C. Wainwright Global Investment ConferenceTuHURA Biosciences will present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, Sept.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9NPZmG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351765","title":"Tuhura Biosciences Draws $1.5 Million from Parkview Holdings Revolving Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351765","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351765?lang=en_us&edition=fundamental","pubTime":"2026-09-05 05:00","pubTimestamp":1788555659,"startTime":"0","endTime":"0","summary":"Tuhura Biosciences draws $1.5 million from Parkview Holdings revolving credit facilityTuhura Biosciences drew USD 1.5 million on Sept. 2 under its revolving credit facility with Parkview Holdings One.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6FK9s7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749608","title":"Analysts’ Top Healthcare Picks: CVS Health (CVS), TuHURA Biosciences (HURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662749608?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:20","pubTimestamp":1787768419,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVS Health (CVS) and TuHURA Biosciences (HURA) with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cvs-health-cvs-tuhura-biosciences-hura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cvs-health-cvs-tuhura-biosciences-hura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0061475181.USD","LU0208291251.USD","LU0211331839.USD","IE0002270589.USD","BK4504","LU0006061336.USD","BK4137","CVS","LU0072461881.USD","LU1059921491.USD","HURA","LABU","HCSG","LU0070302665.USD","LU2357627491.SGD","IE00BZ1G4Q59.USD","IHF","IE00BKVL7J92.USD","LU1236620750.USD","IE00B19Z3B42.SGD","LU1236620834.HKD","LU1699723380.USD","LU2125909593.SGD","LU0320765489.SGD","BK4581","LU1983299246.USD","LU0859254822.USD","BK4585","LU0432979614.USD","LU0128526141.USD","BK4139","IE00B7SZLL34.SGD","LU0162691827.USD","LU2125909247.SGD","LU2433249047.HKD","IE00BSNM7G36.USD","LU0029874061.USD","BK4550","XLV","RTH","LU1923622614.USD","XBI","BK4196","IE00B19Z3581.USD","LU1571399168.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661529062","title":"Tuhura Biosciences Draws $650,000 from Parkview Revolving Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2661529062","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661529062?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:06","pubTimestamp":1787346411,"startTime":"0","endTime":"0","summary":"Tuhura Biosciences draws $650,000 from Parkview revolving credit facilityTuHURA Biosciences borrowed USD 650,000 under its revolving credit facility with Parkview Holdings One.Revolver provides up to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL151sNk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660547558","title":"Tuhura Biosciences Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660547558","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660547558?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:01","pubTimestamp":1787173268,"startTime":"0","endTime":"0","summary":"Tuhura Biosciences holds annual shareholder meetingTuhura Biosciences held its annual shareholder meeting on Aug. 18, 2026.Shareholders backed a plan to issue 1,878,287 common shares under a fee lette","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL6GFKx5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660462749","title":"TuHURA Biosciences Price Target Maintained with a $9.00/Share by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2660462749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660462749?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:29","pubTimestamp":1787056140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HURA/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659499121","title":"TuHURA Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659499121","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659499121?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:02","pubTimestamp":1786741331,"startTime":"0","endTime":"0","summary":"TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings SummaryTuHURA Biosciences IncHURA.OQreported a quarterly adjusted loss of 14 cents per share for the quarter ended June ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B1LG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659614933","title":"TuHURA Biosciences Q2 EPS $(0.14) Beats $(0.15) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659614933","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659614933?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:04","pubTimestamp":1786709098,"startTime":"0","endTime":"0","summary":"TuHURA Biosciences (NASDAQ:HURA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 33.33 percent increase over losses of $(0.21) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61205418/tuhura-biosciences-q2-eps-0-14-beats-0-15-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659146570","title":"Tuhura Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659146570","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659146570?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:45","pubTimestamp":1786707900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA5NWDCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659616146","title":"Press Release: TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659616146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659616146?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:45","pubTimestamp":1786707900,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Aug. 14, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc.  , a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today reported financial results for the Company's second quarter ended June 30, 2026, and provided a corporate update.\"We have made significant progress in advancing all our programs forward and are positioned to continue driving towards several anticipated milestones targeted for the second half of the year,\" said Dr. James Bianco, President and CEO of TuHURA Biosciences. \"In the second half, we anticipate receiving safe-to-proceed feedback from FDA and to initiating our Phase 1b/2 trial of VISTA in mutNPM1 r/r AML, initiating our in vivo POC studies for MDSC Inhibitors , potentially receiving orphan drug designation in Merkel cell carcinoma  for IFx-2.0, and potentially receiving orphan drug designation in AML for TBS-2025. The recent $50 million term credit facility made available to us by our largest ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4232","BK4139","HURA","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160230","title":"Tuhura Biosciences Draws $650,000 from Parkview Revolving Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160230?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:01","pubTimestamp":1786654906,"startTime":"0","endTime":"0","summary":"Tuhura Biosciences draws $650,000 from Parkview revolving credit facilityTuhura Biosciences drew USD 650,000 under its revolving credit facility with Parkview Holdings One on Aug. 7, 2026.The revolvin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL9DjWp2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659880900","title":"TuHURA Biosciences Inc Expected to Post a Loss of 14 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2659880900","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659880900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:11","pubTimestamp":1786565480,"startTime":"0","endTime":"0","summary":"TuHURA Biosciences Inc <HURA.OQ> expected to post a loss of14cents a share - Earnings PreviewTuHURA Biosciences IncHURA.OQHURA.Ois expected to  show no change in quarterly revenue when it reports  res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N449236:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658179749","title":"Tuhura Biosciences Releases Corporate Deck Outlining Strategy to Tackle Cancer Immunotherapy Resistance","url":"https://stock-news.laohu8.com/highlight/detail?id=2658179749","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658179749?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:16","pubTimestamp":1786472170,"startTime":"0","endTime":"0","summary":"Tuhura Biosciences releases corporate deck outlining strategy to tackle cancer immunotherapy resistanceTuhura Biosciences highlighted a Phase 3 accelerated-approval study of IFx-2.0 with pembrolizumab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL49LLSc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655689812","title":"Tuhura Biosciences Draws $1.5 Million from Parkview Revolving Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2655689812","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655689812?lang=en_us&edition=fundamental","pubTime":"2026-07-30 05:22","pubTimestamp":1785360145,"startTime":"0","endTime":"0","summary":"Tuhura Biosciences draws $1.5 million from Parkview revolving credit facilityTuhura Biosciences drew USD 1.5 million under its revolving credit facility with Parkview Holdings One.The credit facility,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL9v3gVN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649958134","title":"Tuhura Biosciences Draws $1.9 Million from Parkview Revolving Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2649958134","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649958134?lang=en_us&edition=fundamental","pubTime":"2026-07-08 05:31","pubTimestamp":1783459867,"startTime":"0","endTime":"0","summary":"Tuhura Biosciences draws $1.9 million from Parkview revolving credit facilityTuHURA Biosciences drew USD 1.9 million on June 30, 2026 under a revolving credit facility with Parkview Holdings One.The f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL3fkRhB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}]}}